M&A Deal Summary |
|
|---|---|
| Date | 2013-09-09 |
| Target | Laboratorios Casen Fleet S.L.U. |
| Sector | Life Science |
| Buyer(s) | Recordati |
| Deal Type | Add-on Acquisition |
| Deal Value | 93M EUR |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1926 |
| Sector | Medical Products |
| Employees | 4,450 |
| Revenue | 2.3B EUR (2024) |
Recordati is an international pharmaceutical group dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, other Central and Eastern European countries, Turkey, North Africa, the United States of America, Canada, Mexico and in some South American countries. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati was founded in 1926 and is based in Milan, Italy.
| DEAL STATS | # |
|---|---|
| Overall | 13 of 17 |
| Sector: Life Science M&A | 8 of 10 |
| Type: Add-on Acquisition M&A Deals | 11 of 15 |
| Country: Spain M&A | 2 of 2 |
| Year: 2013 M&A | 3 of 4 |
| Size (of disclosed) | 3 of 13 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-09-09 |
Laboratorios Casen Fleet S.L.U.
Pozuelo de Alarcón, Spain Laboratorios Casen Fleet, S.L.U. is a Spanish pharmaceutical company. |
Buy | €93M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-11-01 |
Opalia Pharma S.A.
Tunisia Opalia Pharma is a pharmaceutical company manufacturing generics under the brand name of Opalia. Its sales mainly cover the Tunisian market, with exports to Francophone Sub-Saharan Africa, North Africa and the Middle East. Opalia has a portfolio of around 130 products and holds approximately 120 drug registrations for the Tunisian market. |
Buy | - |
